Bifidobacterium animalis subsp. lactis XLTG11
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bifidobacterium animalis subsp. lactis XLTG11, covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants [Phase 2]